PKG1 exhibits tumor suppressor properties, while cGMP-dependent PKG2 has been reported to inhibit the proliferation of certain cancer cells, including glioma cells, and promote apoptosis in breast cancer cells. Here, PRKG1 is linked to neoplasm.